Corteva, Inc. (CTVA) earnings: what the market saw

Most coverage stops at beat or miss. This lines up what the company actually filed against what analysts expected, so you can see what the market saw. Two facts here, the rest with a free account.

See what CTVA’s filing said, free

See what the filing said, sign up free →

The headline doesn’t explain it. Two facts first:

The stock fell 24% on the day of its Nov 12, 2026 report, while the S&P 500 fell 0.4%.
Earnings per share $0.06, below the $0.10 analysts expected before the report (July to September 2026).

Revenue against what analysts expected
The company’s outlook against what analysts expected
Margins, cash and debt for the quarter
What the filing said that the headlines skipped
How the stock moved after its last eight reports

The same free account also opens:

ReadR, the chart side: paste any chart and it tells you what the price has been doing, in plain English.
The Fair Value Screener: every company analysed, ranked by how far price sits from its range.
A watchlist with alerts: keep CTVA next to its fair-value range and get an email when the price crosses it.

Not CTVA? Type the stock you actually care about and you get the same analysis for it.

3 full analyses and 3 chart reads on ReadR, over 7 daysNo cardOne free account covers both apps

What the stock is worth

$9.43 Undervalued, overvalued or fair?

The valuation methods put a range on what one CTVA share is worth. A free account shows it, and where today’s price sits against it.

After hours $9.37 ▼ 0.64% (not used in the valuation)

Where does today’s price sit?

See CTVA’s range, sign up free →

The range was worked out on October 31, 2026 from the company’s reported numbers. The price is live. No card needed, and Google sign-up takes a few seconds.

Own CTVA? Put it on a watchlist and keep it next to its fair value range. With Pro, you get an email when the price crosses it. Watch CTVA →

Educational tool, not investment advice. These are automated estimates from third-party data, impersonal and not tailored to anyone's situation. Data can be inaccurate and model assumptions can be wrong. We are not a registered investment adviser or broker-dealer. Always do your own research. See our methodology and terms.